L-Mag (L-Mag)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsp

homeopathic dissolving tablets

Composition:
For 1 tablet:

Active components:

Magnesia muriatica (Magnesia muriatica) D1

0.05 g

Magnesia bromata (Magnesia bromate) D 4

0.01 g

Magnesia phosphorica (Magnesia phosphoric acid) D 1

0.05 g

Plumbum metallicum (Plumbum Metallicum) D8

0.01 g

Kalium phosphoricum (Kalium phosphoricum) D 5

0.01 g

Ambra grísea (Ambra Grisea) D 8

0.01 g

Auxiliary components:

Magnesium stearate

0.02 g

Rice starch

0.02 g

Sucrose

0.0625 g

Lactose

0.7575 g

Tablet weight: 1,000 g
Description:

Tablets of white color of flat-cylindrical form with a bevel, on both sides of the tablet it is marked "LEHNING".

Pharmacotherapeutic group:Homeopathic Remedy
Indications:In pathological conditions, leading to a deficiency of magnesium in the body (confirmed by laboratory studies), including: with the syndrome of reduced absorption of magnesium; with stress, neurovegetative disorders, spasms caused by a deficiency of magnesium in the body.
Contraindications:

Hypersensitivity to the components of the drug. Children under 6 years.

Pregnancy and lactation:

Reception of a homeopathic preparation of L-MAG during pregnancy and during a lactemia is possible only after preliminary consultation with the doctor.

Dosing and Administration:

The tablet should be kept in the mouth until it is completely absorbed. The drug is used in children over 6 years and adults 1-2 tablets 2 times a day for 30 minutes before or 1 hour after eating. The course of treatment is 2 months.

Pediatric Use

The use of the homeopathic drug L-MAG in children over 6 years of age is carried out by appointment and under the supervision of a doctor.

Side effects:

Allergic reactions are possible.

Overdose:

So far, no cases of overdose have been reported.

Interaction:

Not described.

Special instructions:

The composition of the drug includes lactose, and therefore it is not recommended to appoint patients with congenital galactosemia, glucose malabsorption syndrome or galactose, or with congenital lactose insufficiency.

Form release / dosage:Homoepatic resorption tablets.
Packaging:

For 15 tablets in a blister made of polyvinylchloride film and aluminum foil. For 3 or 6 blisters together with the instructions for use are placed in a cardboard box.

Storage conditions:

At a temperature of no higher than 25 ° C.

Keep out of the reach of children!

Shelf life:

5 years.

Do not use after the expiry date printed on the package.

Terms of leave from pharmacies:On prescription
Registration number:LSR-002802/08
Date of registration:17.04.2008
Expiration Date:Unlimited
The owner of the registration certificate:Laboratory Lening S.A.S.Laboratory Lening S.A.S. France
Manufacturer: & nbsp
Representation: & nbspVetta-M, OOOVetta-M, OOO
Information update date: & nbsp21.03.2018
Illustrated instructions
    Instructions
    Up